Type 2 inflammation in asthma and other airway diseases.


Journal

ERJ open research
ISSN: 2312-0541
Titre abrégé: ERJ Open Res
Pays: England
ID NLM: 101671641

Informations de publication

Date de publication:
Jul 2022
Historique:
received: 22 10 2021
accepted: 22 02 2022
entrez: 4 8 2022
pubmed: 5 8 2022
medline: 5 8 2022
Statut: epublish

Résumé

Chronic inflammatory airway diseases, including asthma, chronic rhinosinusitis, eosinophilic COPD and allergic rhinitis are a global health concern. Despite the coexistence of these diseases and their common pathophysiology, they are often managed independently, resulting in poor asthma control, continued symptoms and poor quality of life. Understanding disease pathophysiology is important for best treatment practice, reduced disease burden and improved patient outcomes. The pathophysiology of type 2 inflammation is driven by both the innate immune system triggered by pollutants, viral or fungal infections involving type 2 innate lymphoid cells (ILC2) and the adaptive immune system, triggered by contact with an allergen involving type 2 T-helper (Th2) cells. Both ILC2 and Th2 cells produce the type-2 cytokines (interleukin (IL)-4, IL-5 and IL-13), each with several roles in the inflammation cascade. IL-4 and IL-13 cause B-cell class switching and IgE production, release of pro-inflammatory mediators, barrier disruption and tissue remodelling. In addition, IL-13 causes goblet-cell hyperplasia and mucus production. All three interleukins are involved in trafficking eosinophils to tissues, producing clinical symptoms characteristic of chronic inflammatory airway diseases. Asthma is a heterogenous disease; therefore, identification of biomarkers and early targeted treatment is critical for patients inadequately managed by inhaled corticosteroids and long-acting β-agonists alone. The Global Initiative for Asthma guidelines recommend add-on biological (anti IgE, IL-5/5R, IL-4R) treatments for those not responding to standard of care. Targeted therapies, including omalizumab, mepolizumab, reslizumab, benralizumab, dupilumab and tezepelumab, were developed on current understanding of the pathophysiology of type 2 inflammation. These therapies offer hope for improved management of type 2 inflammatory airway diseases.

Identifiants

pubmed: 35923421
doi: 10.1183/23120541.00576-2021
pii: 00576-2021
pmc: PMC9339769
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Informations de copyright

Copyright ©The authors 2022.

Déclaration de conflit d'intérêts

Conflict of interest: J. Maspero reports grants and personal fees from AstraZeneca, MSD, Novartis, and Sanofi, personal fees from Uriach and Inmunotek, and grants and nonfinancial support from GSK. Conflict of interest: Y. Adir reports personal fees from Teva and Sanofi, and grants and personal fees from GSK and AstraZeneca. Conflict of interest: M. Al-Ahmad has nothing to disclose. Conflict of interest: C. Celis-Preciado reports grants and personal fees from AstraZeneca and GSK, grants from Boehringer, and personal fees from Novartis and Sanofi. Conflict of interest: F.D. Colodenco has nothing to disclose. Conflict of interest: P. Giavina-Bianchi has nothing to disclose. Conflict of interest: H. Lababidi has nothing to disclose. Conflict of interest: O. Ledanois is an employee of Sanofi. Conflict of interest: B. Mahoub has nothing to disclose. Conflict of interest: D-W. Perng has nothing to disclose. Conflict of interest: J.C. Vazquez reports personal fees from AstraZeneca, Boehringer Ingelheim and Sanofi. Conflict of interest: A. Yorgancioglu reports grants/research support from AstraZeneca, MSD, and Sanofi; honoraria/consultation fees from Abdi İbrahim, AstraZeneca, Chiesi, DEVA, GSK, Novartis Sandoz and Sanofi; and other support from ERS, GARD, GINA, Turkish MoH and WHO.

Références

Allergol Int. 2012 Dec;61(4):589-95
pubmed: 22918213
Pediatr Allergy Immunol. 2000 Aug;11(3):162-7
pubmed: 10981525
J Laryngol Otol. 2005 Jul;119(7):543-9
pubmed: 16175980
Allergy. 2011 Sep;66(9):1216-23
pubmed: 21605125
Annu Rev Pathol. 2017 Jan 24;12:331-357
pubmed: 27959637
Laryngoscope. 2019 Sep;129(9):1969-1975
pubmed: 30720213
J Investig Allergol Clin Immunol. 2016;26(4):256-62
pubmed: 27373924
PLoS One. 2018 Apr 2;13(4):e0195055
pubmed: 29608582
J Allergy Clin Immunol. 2007 Feb;119(2):405-13
pubmed: 17291857
Rhinology. 2010 Dec;48(4):420-5
pubmed: 21442078
Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3730-4
pubmed: 8097323
Clin Exp Allergy. 2015 Feb;45(2):328-46
pubmed: 25482020
Chest. 2019 Jul;156(1):141-149
pubmed: 31082387
Mediators Inflamm. 2015;2015:819194
pubmed: 26783384
J Allergy Clin Immunol. 2008 Mar;121(3):685-91
pubmed: 18328894
Am J Respir Crit Care Med. 2011 Nov 15;184(10):1125-32
pubmed: 21852542
J Asthma. 2016 Aug;53(6):635-43
pubmed: 27064727
Curr Allergy Asthma Rep. 2016 Jan;16(1):1
pubmed: 26677109
Proc Natl Acad Sci U S A. 1988 Sep;85(18):6880-4
pubmed: 2970644
Eur Respir J. 2017 Nov 22;50(5):
pubmed: 29167301
J Allergy Clin Immunol. 1999 Jul;104(1):79-84
pubmed: 10400843
Eur Respir J. 2014 Dec;44(6):1697-700
pubmed: 25323230
Am J Respir Crit Care Med. 2015 Sep 15;192(6):682-94
pubmed: 26067893
J Allergy Clin Immunol. 2017 Jun;139(6):1752-1761
pubmed: 28583447
Respirology. 2009 Jul;14(5):729-33
pubmed: 19659651
Am J Respir Crit Care Med. 2010 Feb 15;181(4):315-23
pubmed: 19892860
N Engl J Med. 2018 Jun 28;378(26):2486-2496
pubmed: 29782217
J Allergy Clin Immunol. 2016 May;137(5):1449-1456.e4
pubmed: 26949058
Allergy. 2020 May;75(5):1188-1204
pubmed: 31838750
N Engl J Med. 2018 Sep 13;379(11):1060-1070
pubmed: 30207919
Rhinology. 2020 Feb 20;58(Suppl S29):1-464
pubmed: 32077450
Curr Allergy Asthma Rep. 2013 Oct;13(5):415-20
pubmed: 24026573
J Allergy Clin Immunol Pract. 2017 Jul - Aug;5(4):1015-1024.e8
pubmed: 28017629
Nat Rev Immunol. 2013 Aug;13(8):607-14
pubmed: 23827958
Eur Ann Allergy Clin Immunol. 2010 Jun;42(3):120-4
pubmed: 20648775
Eur Respir J. 2005 Nov;26(5):812-8
pubmed: 16264041
Respir Med. 2005 May;99(5):553-8
pubmed: 15823451
J Allergy Clin Immunol. 1995 Dec;96(6 Pt 2):1145-51
pubmed: 8543771
ERJ Open Res. 2020 Jul 06;6(2):
pubmed: 32665943
Eur Respir J. 2009 Apr;33(4):897-906
pubmed: 19336592
Allergy. 2008 Apr;63 Suppl 86:8-160
pubmed: 18331513
N Engl J Med. 2017 Sep 7;377(10):965-976
pubmed: 28877019
Int Immunol. 1991 Jun;3(6):599-607
pubmed: 1888709
Am J Rhinol Allergy. 2012 Jan-Feb;26(1):1-6
pubmed: 22391065
Lancet. 2006 Aug 26;368(9537):780-93
pubmed: 16935689
Int Arch Allergy Immunol. 2016;170(2):122-31
pubmed: 27637004
Environ Int. 2013 Sep;59:41-52
pubmed: 23770580
Lancet. 2017 Sep 16;390(10100):1211-1259
pubmed: 28919117
Allergy. 2006 Sep;61(9):1047-53
pubmed: 16918506
NPJ Prim Care Respir Med. 2015 Jul 09;25:15026
pubmed: 26158805
PLoS One. 2018 Aug 23;13(8):e0202624
pubmed: 30138415
J Asthma. 2006 Jan-Feb;43(1):1-7
pubmed: 16448958
J Occup Environ Med. 2014 Apr;56(4):425-30
pubmed: 24662951
Nat Rev Drug Discov. 2016 Jan;15(1):35-50
pubmed: 26471366
Ann Rheum Dis. 2009 Jul;68(7):1119-24
pubmed: 18684744
Bioanalysis. 2016 Feb;8(4):323-32
pubmed: 26847873
Chest. 2003 Nov;124(5):1781-8
pubmed: 14605049
J Occup Environ Med. 2009 Jul;51(7):780-5
pubmed: 19528828
Respir Med. 2014 Dec;108(12):1723-32
pubmed: 25456708
Allergy. 2012 Jan;67(1):91-8
pubmed: 22050239
Recent Pat Inflamm Allergy Drug Discov. 2013 Jan 1;7(1):62-95
pubmed: 23140569
J Allergy Clin Immunol Pract. 2014 Nov-Dec;2(6):703-8
pubmed: 25439360
Allergy. 2018 Aug;73(8):1673-1685
pubmed: 29405354
J Allergy Clin Immunol. 2012 Mar;129(3 Suppl):S65-87
pubmed: 22386510
Curr Allergy Asthma Rep. 2005 May;5(3):252-8
pubmed: 15842964
Eur Respir J. 2018 Feb 14;51(2):
pubmed: 29444915
Allergy. 2018 Jul;73(7):1369-1382
pubmed: 29178130
J Clin Invest. 2018 Mar 1;128(3):997-1009
pubmed: 29400693
N Engl J Med. 2014 Sep 25;371(13):1189-97
pubmed: 25199060
Am J Respir Crit Care Med. 2013 Jan 1;187(1):49-57
pubmed: 23155140
Allergy. 2018 Mar;73(3):683-695
pubmed: 29072882
N Engl J Med. 2011 Sep 22;365(12):1088-98
pubmed: 21812663
Allergy. 2008 May;63(5):564-9
pubmed: 18394130
Laryngoscope. 2019 Mar;129(3):E110-E117
pubmed: 30570137
Allergy Asthma Immunol Res. 2017 Jul;9(4):299-306
pubmed: 28497916
PLoS One. 2019 Jan 24;14(1):e0210915
pubmed: 30677059
Respir Med. 2012 Jan;106(1):47-56
pubmed: 21890336
J Allergy Clin Immunol. 2014 Feb;133(2):388-94
pubmed: 24075231
Otolaryngol Head Neck Surg. 2006 Apr;134(4):609-12
pubmed: 16564382
J Clin Cell Immunol. 2014 Apr;5(2):
pubmed: 25419479
N Engl J Med. 2018 Jun 28;378(26):2475-2485
pubmed: 29782224
NPJ Prim Care Respir Med. 2014 Jun 12;24:14009
pubmed: 24921985
World Allergy Organ J. 2019 Jan 26;12(1):100007
pubmed: 30937132
Eur Respir J. 2002 Jan;19(1):61-7
pubmed: 11843329
Clin Exp Allergy. 2017 Feb;47(2):161-175
pubmed: 28036144
Allergol Int. 2015 Apr;64(2):121-30
pubmed: 25838086
Respirology. 2017 May;22(4):651-661
pubmed: 28328160
Front Pediatr. 2017 Mar 03;5:44
pubmed: 28316969
Allergy. 2019 Dec;74(12):2312-2319
pubmed: 31090937
Asian Pac J Allergy Immunol. 2009 Mar;27(1):27-33
pubmed: 19548627
Lancet Respir Med. 2015 May;3(5):355-66
pubmed: 25736990
Eur Respir Rev. 2012 Mar 1;21(123):66-74
pubmed: 22379176
Lancet Respir Med. 2016 Jun;4(6):454-62
pubmed: 27061878
Cytokine. 2015 Sep;75(1):57-61
pubmed: 26088754
Eur Respir J. 2014 Feb;43(2):343-73
pubmed: 24337046
J Allergy Clin Immunol Pract. 2017 Jul - Aug;5(4):1061-1070.e3
pubmed: 28286156
Clin Exp Allergy. 2013 Aug;43(8):850-73
pubmed: 23889240
Am J Respir Crit Care Med. 2004 Oct 15;170(8):836-44
pubmed: 15256389
Clin Med (Lond). 2011 Aug;11(4):376-80
pubmed: 21853839
Clin Rev Allergy Immunol. 2019 Apr;56(2):219-233
pubmed: 30206782
Allergy. 2010 Oct;65(10):1290-7
pubmed: 20384618
J Allergy Clin Immunol. 2015 Dec;136(6):1431-1440
pubmed: 26654192
Expert Rev Clin Immunol. 2017 May;13(5):425-437
pubmed: 28277826
Nat Rev Drug Discov. 2013 Feb;12(2):117-29
pubmed: 23334207
J Asthma. 2009 Nov;46(9):861-6
pubmed: 19905909
World Allergy Organ J. 2017 Aug 21;10(1):28
pubmed: 28855973
J Asthma. 2018 Feb;55(2):208-219
pubmed: 28586296
Int Forum Allergy Rhinol. 2014 May;4(5):361-70
pubmed: 24510479
Tissue Barriers. 2013 Apr 1;1(2):e24333
pubmed: 24665390
J Immunol Res. 2016;2016:2643297
pubmed: 28127565
Int Forum Allergy Rhinol. 2016 Feb;6 Suppl 1:S22-209
pubmed: 26889651
Am J Respir Cell Mol Biol. 2007 Jul;37(1):97-104
pubmed: 17347445
Sleep Med. 2008 Jul;9(5):494-9
pubmed: 17766180
Medicina (Kaunas). 2008;44(4):257-65
pubmed: 18469501
Allergy. 2019 Jan;74(1):28-39
pubmed: 30216468
Am J Rhinol. 2008 Mar-Apr;22(2):115-21
pubmed: 18416964
Science. 1991 Nov 1;254(5032):707-10
pubmed: 1948049
Curr Opin Allergy Clin Immunol. 2019 Aug;19(4):379-386
pubmed: 31169594
J Allergy Clin Immunol Pract. 2019 May - Jun;7(5):1462-1468
pubmed: 30368004
Lancet. 2016 Oct 29;388(10056):2128-2141
pubmed: 27609406
Nat Rev Immunol. 2015 Jan;15(1):57-65
pubmed: 25534623
Eur Respir J. 2015 Nov;46(5):1308-21
pubmed: 26357963
J Allergy Clin Immunol. 2002 Apr;109(4):621-6
pubmed: 11941310
J Allergy Clin Immunol. 2017 Apr;139(4):1167-1175.e2
pubmed: 27726946
Eur Respir J. 2013 Nov;42(5):1402-11
pubmed: 23100505
Allergy. 2013 Oct;68(10):1314-21
pubmed: 24107218
Cell Tissue Res. 2017 Mar;367(3):551-569
pubmed: 28190087
Rhinology. 2019 Feb 1;57(1):32-42
pubmed: 29911211
Ann Allergy Asthma Immunol. 2004 May;92(5):512-22
pubmed: 15191019
Medicina (Kaunas). 2019 Apr 05;55(4):
pubmed: 30959833
Respirology. 2007 Mar;12(2):272-6
pubmed: 17298462
J Allergy Clin Immunol. 2018 Jan;141(1):110-116.e7
pubmed: 28456623
J Exp Med. 1994 Jan 1;179(1):135-43
pubmed: 7903680
J Allergy Clin Immunol Pract. 2019 Feb;7(2):589-596.e3
pubmed: 30193936
Lancet. 2015 Sep 12;386(9998):1086-96
pubmed: 26383000
Allergy. 2017 Feb;72(2):282-290
pubmed: 27392210
J Allergy Clin Immunol. 2007 Sep;120(3):565-9
pubmed: 17655920
JAMA. 2015 Sep 1;314(9):926-39
pubmed: 26325561
Eur Respir J. 2017 May 1;49(5):
pubmed: 28461301
Int Arch Allergy Immunol. 2018;177(4):281-289
pubmed: 30423562
Curr Treat Options Allergy. 2018;5(4):436-444
pubmed: 30524933
Lancet Respir Med. 2014 Feb;2(2):131-40
pubmed: 24503268
Allergy. 2005 Apr;60(4):452-8
pubmed: 15727575
J Clin Invest. 2016 Jun 1;126(6):2367-71
pubmed: 27183390
J Allergy Clin Immunol. 2020 Aug;146(2):337-343.e6
pubmed: 32417132
J Exp Med. 2001 Sep 17;194(6):809-21
pubmed: 11560996
Laryngoscope. 2013 Jan;123(1):36-41
pubmed: 23070897
World Allergy Organ J. 2014 Oct 27;7(1):25
pubmed: 25379119
Respir Med. 2012 Jan;106(1):9-14
pubmed: 22112783
J Asthma. 2008 Nov;45(9):758-65
pubmed: 18972291
J Allergy Clin Immunol. 2007 Nov;120(5):997-1009; quiz 1010-1
pubmed: 17681364
Int Arch Allergy Immunol. 2009;148(2):87-98
pubmed: 18799888

Auteurs

Jorge Maspero (J)

Fundacion CIDEA (Centro de Investigacion de Enfermedades Alergicas y Respiratorias), University of Buenos Aires, Buenos Aires, Argentina.

Yochai Adir (Y)

Pulmonary Division, Lady Davis Carmel Medical Center, Faculty of Medicine, The Technion, Institute of Technology, Haifa, Israel.

Mona Al-Ahmad (M)

Microbiology Dept, Faculty of Medicine, Kuwait University, Kuwait City, Kuwait.

Carlos A Celis-Preciado (CA)

Pulmonary Unit, Internal Medicine Department, Hospital Universitario San Ignacio, Bogota, Colombia.
Faculty of Medicine, Pontificia Universidad Javeriana, Bogota, Colombia.

Federico D Colodenco (FD)

Pulmonology, Hospital De Rehabilitación Respiratoria María Ferrer, Buenos Aires, Argentina.

Pedro Giavina-Bianchi (P)

Clinical Immunology and Allergy Division, University of Sao Paulo, Sao Paulo, Brazil.

Hani Lababidi (H)

King Fahad Medical City, Riyadh, Saudi Arabia.

Olivier Ledanois (O)

Sanofi Genzyme, Paris, France.

Bassam Mahoub (B)

Dept of Pulmonary Medicine and Allergy and Sleep Medicine, Rashid Hospital, Dubai, United Arab Emirates.
Dept of Medicine and Chest Disease, University of Sharjah, Sharjah, United Arab Emirates.

Diahn-Warng Perng (DW)

Taipei Veterans General Hospital, Taipei, Taiwan.

Juan C Vazquez (JC)

Instituto Nacional de Enfermedades Respiratorias, Mexico City, Mexico.

Arzu Yorgancioglu (A)

Dept of Chest Diseases, Faculty of Medicine, Manisa Celal Bayar University, Manisa, Turkey.

Classifications MeSH